Norethisterone acetate oxime: Difference between revisions
Content deleted Content added
No edit summary |
No edit summary |
||
| Line 64: | Line 64: | ||
[[Category:Acetate esters]] |
[[Category:Acetate esters]] |
||
[[Category:Androgens and anabolic steroids]] |
[[Category:Androgens and anabolic steroids]] |
||
| ⚫ | |||
[[Category:Progestogens]] |
[[Category:Progestogens]] |
||
| ⚫ | |||
Revision as of 03:20, 8 December 2016
 | |
| Clinical data | |
|---|---|
| Other names | Norethisterone-3-oxime acetate |
| Routes of administration | Oral |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| Chemical and physical data | |
| Formula | C22H29NO3 |
| Molar mass | 355.47056 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Norethisterone acetate oxime (developmental code names ORF-5263, So-36), or norethindrone acetate oxime, is a steroidal progestin of the 19-nortestosterone group that was developed as a postcoital contraceptive but was never marketed.[1] It is the 3-oxime, 17β-acetate ester of norethisterone.[1]
See also
References
- ^ a b J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 886–. ISBN 978-1-4757-2085-3.
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
 | This article about a steroid is a stub. You can help Wikipedia by expanding it. |